…tissues. Pain is produced by pro-inflammatory agents that also lead to an increased sensitivity to feeling pain and an extreme response to pain, or hyperalgesia. If the condition that…
…treatment of pain, particularly chronic pain, and suppression of hyperalgesia. Most published studies involve endocannabinoids, delta-9 tetrahydrocannabinol (THC), or synthetic cannabinoids. The cannabinoid-opioid interactions and “opioid-sparing effect” of cannabinoids has…
…care. The focus is often pain. Cannabis use for pain can be traced back thousands of years. Observationally in research, the response to pain in individuals has been favorable…
…care. The focus is often pain. Cannabis use for pain can be traced back thousands of years. Observationally in research, the response to pain in individuals has been favorable…
…an analytical method was developed and validated for the determination of Δ9-THC and for its major circulating metabolites 11-hydroxy-Δ9-tetrahydrocannabinol (11-OH-THC) and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in human plasma. Δ9-THC, 11-OH-THC, and…
…year chronic pain conditions, duration of chronic non-cancer pain, pain self-efficacy, whether pain was neuropathic, lifetime and past 12-month cannabis use, number of days cannabis was used in the past…
…cannabinoid therapy include being an anticonvulsant, anti-inflammatory, immunosuppressive, anti-nausea, anti-vomiting, anti-anxiety, antidepressant, antipsychotic, antioxidant, anti-tumoral, neuroprotective agent, anti-degenerative agent, and spermatogenesis agent. What is THC? Tetrahydrocannabinol, or THC, is the…
…of delta-8-THC than delta-9-THC to prevent vomiting due to antineoplastic treatment. They were administered 480 treatments of delta-8-THC and all participants reported feeling relief. This shows promise for delta-8-THC as…
…THCV strain. It probably has the highest amount of THCV in the market with most types having about 5% THCV and about 22% THC. Other Ways to Avoid the…
…chronic pain, categorized as active (within 30 days), past (>31 days), or never use (referent). Measures were pain intensity (primary) and interference, Widespread Pain Index, and number of chronic pain…
